Drawing for SYNNPHB

USPTO serial 79291526

SYNNPHB

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PAINTER, VALERIYA SHERMAN
Law office
TMO LAW OFFICE 129 - SENIOR ATTORNEY

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SYNNPHB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry; biological preparations for use in industry and science; biological preparations for use in manufacture; biological preparations for use in science; biological preparation for use in cell cultures other than for medical or veterinary use; blood culture media for scientific use; biochemicals, namely, precursors for in vitro genetic engineering use; chemical preparations for use in DNA analysis [other than medical]; enzymes for use as biochemical catalysts; biochemicals, namely, polypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use; diagnostic test kits for use in science, comprised of patch preparations; diagnostic test kits for scientific use, comprised of reagents, processing chemicals; biochemicals for use in industry and science; molecular biological products for use in industry and science; plasmids for use in industry and science; chromosomes for use in industry and scienceACTIVE—
005Preparations for detecting genetic predispositions for medical purposes; biological implants; biological tissue for implantation; biological adjuvants for medical purposes; biological reagents for medical use; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes; biological tissue cultures for medical purposes; bone growth media consisting of biological materials for medical purposes; human plasma protein; blood plasma; blood components; blood substitutes; blood protein fractions; DNA synthesis inhibitors; chemical preparations for use in DNA analysis [medical]; cells for medical use; diagnostic medical reagents for medical use in diagnosing inflammatory, infections, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; diagnostic test kits for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological endocrine, autoimmune and genetic diseases and cancer, comprised of reagents, processing chemicals and patches; medical diagnostic test kits for detecting pathogens in the environmentACTIVE—
009DNA microarrays; DNA chips; biochip sensors; bioreactor for cell culturing; laboratory equipment, namely, laboratory apparatus and laboratory instruments; apparatus for sieve tests, the detection of analytes in samples and the identification of the sample type, together with measurement pattern and kits for building and screening of molecular systems as well as parts for itACTIVE—
042Genetic research; genetic fingerprinting for scientific or medical research purposes; scientific research relating to genetics; scientific research in the field of genetics and genetic engineering; biological laboratory services; biological cloning services; biological research, clinical research and medical research; services of a chemical and/or biological laboratory; blood analysis services; genetic engineering services; DNA screening for scientific research purposes; research and development in the field of microorganisms and cells; scientific services relating to the isolation and cultivation of human tissues and cells; research and development services for third parties in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental testing processes and industrial quality control processes; chemical sieve analysis; scientific and technological services as well as research and design services relating thereto; industrial analysis; industrial research; services of an industrial designer; quality control; authentication services; design and development of computer hardware and software; research in the area of textile dyes; research in the area of textile dyes consisting of bacteriaACTIVE—
044Medical and health services relating to naked DNA, genetics and genetic testing; genetic counselling; blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical diagnostic services [execution of tests and analysis]; execution of medical testsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 18, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 16, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 6, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 19, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 19, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 16, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 16, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 19, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 27, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 27, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 28, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 27, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2020DOCKASSIGNED TO EXAMINER—
Aug 18, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance